Beyang Therapeutics Co., Ltd.
PrivateLast Round
Series A
Aug 12, 2026
Total Funding Raised
$30M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Beyang Therapeutics Co., Ltd. is a biopharmaceutical company that develops novel therapies for ophthalmic and oncological diseases using its proprietary ExCEED drug discovery platform.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Beyang Therapeutics Co., Ltd. Comparables
Compare Beyang Therapeutics Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| neoX Biotech | 84% | |
| MindRank | 83% | |
| HeliXon | 81% | |
Beyang Therapeutics Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Aug 12, 2026 | ||||
| Seed | Feb 19, 2024 | ||||
| Pre Seed | Jul 17, 2023 |
Beyang Therapeutics Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Shanghai Healthcare Capital | Series A |
| Ming Bioventures | Pre Seed |
| YuanBio Venture Capital | Series A |
| Legend Capital | Series A |
| Root Venture Partners | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 17, 2026
Open roles increased to 8, 200% of headcount.
- Aug 12, 2026
$30M round led by Shanghai Healthcare Capital and Legend Capital.
Beyang Therapeutics Co., Ltd. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Beyang Therapeutics Co., Ltd.'s valuation, stock price, and market status.